Krilogy Financial LLC Grows Stock Position in HCA Healthcare, Inc. $HCA

Krilogy Financial LLC boosted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 107.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,966 shares of the company’s stock after acquiring an additional 1,539 shares during the period. Krilogy Financial LLC’s holdings in HCA Healthcare were worth $1,433,000 at the end of the most recent reporting period.

Other institutional investors have also recently modified their holdings of the company. Norges Bank purchased a new stake in HCA Healthcare in the 4th quarter valued at approximately $1,262,513,000. Life Cycle Investment Partners Ltd purchased a new stake in shares of HCA Healthcare in the fourth quarter valued at $374,037,000. Viking Global Investors LP increased its position in HCA Healthcare by 58.5% during the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after purchasing an additional 690,773 shares in the last quarter. Northwestern Mutual Wealth Management Co. lifted its holdings in HCA Healthcare by 4,545.5% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock valued at $309,686,000 after purchasing an additional 649,058 shares in the last quarter. Finally, Danske Bank A S acquired a new position in shares of HCA Healthcare in the third quarter valued at approximately $115,530,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $387.14 on Friday. HCA Healthcare, Inc. has a 12 month low of $330.00 and a 12 month high of $556.52. The company has a market cap of $85.88 billion, a price-to-earnings ratio of 13.31, a price-to-earnings-growth ratio of 1.23 and a beta of 1.12. The stock’s 50-day moving average is $410.50 and its 200-day moving average is $465.84.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The business had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm’s revenue for the quarter was up 4.3% compared to the same quarter last year. During the same period last year, the company posted $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Research analysts anticipate that HCA Healthcare, Inc. will post 30.07 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be issued a dividend of $0.78 per share. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. HCA Healthcare’s payout ratio is presently 10.73%.

Analyst Ratings Changes

Several research firms have commented on HCA. Weiss Ratings cut shares of HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, June 9th. Sanford C. Bernstein lowered their price objective on HCA Healthcare from $503.00 to $413.00 and set a “market perform” rating for the company in a research report on Thursday, June 4th. Robert W. Baird reduced their target price on HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 15th. Barclays dropped their price objective on shares of HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating for the company in a research note on Monday, April 27th. Finally, Truist Financial set a $413.00 target price on shares of HCA Healthcare in a report on Thursday, June 4th. Fifteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $503.00.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.